Voglead GM 1mg/500mg/0.2mg Tablet SR
Marketer
Lead Star Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglead GM 1mg/500mg/0.2mg Tablet SR
Diabex Trio (1mg/500mg/0.2mg) extended-release tablets are classified as antidiabetic agents, a combination therapy for adult type 2 diabetes. This medication helps regulate blood glucose. Diabex Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and appropriate management strategies. Maintain regular mealtimes and carry a quick-acting glucose source. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Uses of Voglead GM 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voglead GM 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglead GM 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Voglead GM 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglead GM 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglead GM 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Voglead GM 1mg/500mg/0.2mg Tablet SR works:
Voglead GM extended-release tablets (1mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglead GM 1mg/500mg/0.2mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Use of Voglead GM 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglead GM tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyUNSAFE
The use of Voglead GM 1mg/500mg/0.2mg Tablet SR is likely inadvisable for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglead GM 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For individuals with mild to moderate hepatic dysfunction, a low initial dose is typically recommended; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Voglead GM 1mg/500mg/0.2mg Tablet SR :
Should you forget a Voglead GM 1mg/500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglead GM 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently